Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation

被引:44
|
作者
Gilbert, Jessica R. [1 ]
Zarate, Carlos A., Jr. [1 ]
机构
[1] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, 10 Ctr Dr,MSC 1282, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Ketamine; Electrophysiology; Gamma; Long-term potentiation; Dynamic causal modeling; NMDA RECEPTOR BLOCKADE; D-ASPARTATE ANTAGONIST; EVOKED-POTENTIALS; OSCILLATIONS; DISORDER; INTERNEURONS; MECHANISMS; FREQUENCY; EFFICACY; TRIAL;
D O I
10.1016/j.pbb.2020.172856
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Over the last two decades, the discovery of ketamine's antidepressant properties has galvanized research into the neurobiology of treatment-resistant depression. Nevertheless, the mechanism of action underlying antidepressant response to ketamine remains unclear. This study reviews electrophysiological studies of ketamine's effects in individuals with depression as well as healthy controls, with a focus on two putative markers of synaptic potentiation: gamma oscillations and long-term potentiation. The review focuses on: 1) measures of gamma oscillations and power and their relationship to both acute, psychotomimetic drug effects as well as delayed antidepressant response in mood disorders; 2) changes in long-term potentiation as a promising measure of synaptic potentiation following ketamine administration; and 3) recent efforts to model antidepressant response to ketamine using novel computational modeling techniques, in particular the application of dynamic causal modeling to electrophysiological data. The latter promises to better characterize the mechanisms underlying ketamine's antidepressant effects.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] SHORT-TERM KETAMINE ADMINISTRATION IN TREATMENT-RESISTANT DEPRESSION: FOCUS ON CARDIOVASCULAR SAFETY
    Szarmach, Joanna
    Cubala, Wieslaw Jerzy
    Wlodarczyk, Adam
    Wiglusz, Mariusz S.
    PSYCHIATRIA DANUBINA, 2019, 31 : S585 - S590
  • [22] Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression
    Fekadu, Abebaw
    Wooderson, Sarah C.
    Rane, Lena J.
    Markopoulou, Kalypso
    Poon, Lucia
    Cleare, Anthony J.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2011, 56 (09): : 549 - 557
  • [23] Immediate and long-term electrophysiological biomarkers of antidepressant-like behavioral effects after subanesthetic ketamine and medial prefrontal cortex deep brain stimulation treatment
    Bergosh, Matthew
    Medvidovic, Sasha
    Zepeda, Nancy
    Crown, Lindsey
    Ipe, Jennifer
    Debattista, Lauren
    Romero, Luis
    Amjadi, Eimon
    Lam, Tian
    Hakopian, Erik
    Choi, Wooseong
    Wu, Kevin
    Lo, Jack Yu Tung
    Lee, Darrin Jason
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [24] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 277 - 277
  • [25] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 277 - 277
  • [26] Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
    Allen, A. P.
    Naughton, M.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    McLoughlin, D. M.
    Cryan, J. F.
    Dinan, T. G.
    Clarke, G.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 306 - 311
  • [27] Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
    Murrough, James W.
    Burdick, Katherine E.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Chang, Lee C.
    Foulkes, Alexandra
    Charney, Dennis S.
    Mathew, Sanjay J.
    Iosifescu, Dan V.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (05) : 1084 - 1090
  • [28] Maintenance of antidepressant effect by dextromethorphan in patients with treatment-resistant depression who respond to ketamine intervention
    Chen, Mu-Hong
    Tsai, Shih-Jen
    MEDICAL HYPOTHESES, 2024, 182
  • [29] Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
    Wilkinson, Samuel T.
    Wright, DaShaun
    Fasula, Madonna K.
    Fenton, Lisa
    Griepp, Matthew
    Ostroff, Robert B.
    Sanacora, Gerard
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2017, 86 (03) : 162 - 167
  • [30] Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol
    Martin, Josh
    Nezhad, Fatemeh Gholamali
    Rueda, Alice
    Lee, Gyu Hee
    Charlton, Colleen E.
    Soltanzadeh, Milad
    Ladha, Karim S.
    Krishnan, Sridhar
    Diaconescu, Andreea O.
    Bhat, Venkat
    PLOS ONE, 2024, 19 (08):